Jefferies Maintains a 'Hold' on IPC The Hospitalist Company (IPCM); Good Story, But Lack of N-T Catalysts

Jefferies maintains a 'Hold' on IPC The Hospitalist Company (NASDAQ: IPCM) price target of $46.00 (from $40.00).

Analyst, Brian Tanquilut, said, "IPCM remains one of the better growth stories in our H/C services coverage universe, and we have a positive bias on the name given our belief that hospitalist services, which generally fall under primary care, are largely immune from potential Medicare cuts. That said, we believe NT upside to the stock is fairly limited given the lack of meaningful catalysts and the stock's current valuation."

For an analyst ratings summary and ratings history on IPC The Hospitalist Company click here. For more ratings news on IPC The Hospitalist Company click here.

Shares of IPC The Hospitalist Company closed at $43.76 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
• UBS Reiterates Buy Rating on Hilton Worldwide (HLT)
• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'